Midatech Bets on Bioasis Merger For Survival
UK Firm Been Through Turbulent Times
Executive Summary
With just enough cash to stay afloat until the first quarter, Midatech is linking up with US-based, Canada-listed Bioasis to create a new rare disease player, Biodexa.